SLC4A10 and atherosclerosis: In summary, this study supports the fact that SLC4A10 weakens the toxic functions of CD8+ T cells in secreting IFN-γ and GZMB via the MAPK pathway, exerting a significant role in decelerating the development of atherosclerosis and facilitating plaque stability.